Back
Panbela Therapeutics Stock Price Chart
Sell
22
PBLA
Panbela Therapeutics
Last Price:
0.44
Seasonality Move:
-4.94%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBLA is experiencing selling pressure, which indicates risk of future bearish movement.
Panbela Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.41 | Buy |
20-day SMA: | 0.42 | Buy |
50-day SMA: | 0.52 | Sell |
200-day SMA: | 12.06 | Sell |
8-day EMA: | 0.43 | Buy |
20-day EMA: | 0.44 | Sell |
50-day EMA: | 1.09 | Sell |
200-day EMA: | 653.94 | Sell |
Panbela Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 44.5 | Sell |
Chaikin Money Flow: | -14427 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.38 - 0.48) | Buy |
Bollinger Bands (100): | (-2.09 - 8.45) | Sell |
Panbela Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Panbela Therapeutics Stock
Is Panbela Therapeutics Stock a Buy?
- Panbela Therapeutics share price is 0.44 while PBLA 8-day simple moving average is 0.41, which is a Buy signal.
- The stock price of PBLA is 0.44 while Panbela Therapeutics 20-day SMA is 0.42, which makes it a Buy.
- Panbela Therapeutics 50-day simple moving average is 0.52 while PBLA share price is 0.44, making it a Sell technically.
- PBLA stock price is 0.44 and Panbela Therapeutics 200-day simple moving average is 12.06, creating a Sell signal.
PBLA Technical Analysis vs Fundamental Analysis
Sell
22
Panbela Therapeutics (PBLA)
is a Sell
Is Panbela Therapeutics a Buy or a Sell?
-
Panbela Therapeutics stock is rated a Sell
The current Panbela Therapeutics [PBLA] share price is $0.44. The Score for PBLA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Panbela Therapeutics Stock Info
Market Cap:
2.14M
Price in USD:
0.44
Share Volume:
32K
Panbela Therapeutics 52-Week Range
52-Week High:
240.00
52-Week Low:
0.35
Sell
22
Panbela Therapeutics (PBLA)
is a Sell
Panbela Therapeutics Share Price Forecast
-
What is the Panbela Therapeutics stock price today?
The Panbela Therapeutics stock price is 0.44 USD today. -
Will PBLA stock go up or go down?
Panbela Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Panbela Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Panbela Therapeutics is overvalued.
Is Panbela Therapeutics Stock a Buy?
- Panbela Therapeutics share price is 0.44 while PBLA 8-day exponential moving average is 0.43, which is a Buy signal.
- The stock price of PBLA is 0.44 while Panbela Therapeutics 20-day EMA is 0.44, which makes it a Sell.
- Panbela Therapeutics 50-day exponential moving average is 1.09 while PBLA share price is 0.44, making it a Sell technically.
- PBLA stock price is 0.44 and Panbela Therapeutics 200-day simple moving average is 653.94, creating a Sell signal.
Fundamental Analysis of Panbela Therapeutics
Is Panbela Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $39.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,220.22 per share, and an increase next year of $3.68 per share.
Technical Analysis of Panbela Therapeutics
Should I short Panbela Therapeutics stock?
- PBLA Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Panbela Therapeutics is a Sell
- Panbela Therapeutics Relative Strength Index (RSI) is 44.5, which suggest Panbela Therapeutics is oversold
- The Bollinger Bands (25) for Panbela Therapeutics is (0.38 - 0.48), which suggest Panbela Therapeutics is a Sell
- The Bollinger Bands (100) for Panbela Therapeutics is (-2.09 - 8.45), which suggest Panbela Therapeutics is a Sell
* Panbela Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.